home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Phase 1/2 Clinical Trial Data for IDE196 Presented at Society for Melanoma Research Congress
Phase 1/2 Clinical Trial Data for IDE196 Presented at Society for Melanoma Research Congress
Post navigation
Previous Post
Previous
Kronos Bio Appoints Biopharma Industry Veteran Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer
Next Post
Next
Neon Therapeutics Announces New Strategic Focus on Novel T Cell Programs